@article{article, title  = {{Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://dx.doi.org/10.1007/s00198-024-07251-w }},

 year = {{2024}},

 month = {{10}},

 author = {{Borgström F and Lorentzon M and Johansson H and Harvey NC and McCloskey E and Willems D and Knutsson D and Kanis JA}},

 doi = {{10.1007/s00198-024-07251-w}},

 journal = {{Osteoporosis International}},

 note = {{Accessed on 2024/12/22}}}